Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Bse Dollex 200
Bse Dollex 200 Performance
Day's Range
Low
₹1,964.05
High
₹1,975.25
52 Week Range
Low
₹1,768.97
High
₹2,265.22
| Previous Close | ₹1,965.75 |
|---|---|
| Day's Range | ₹1,964.05 - ₹1,975.25 |
| Open | ₹1,964.76 |
| 52 Week Range | ₹1,768.97 - ₹2,265.22 |
| Volume | 0 |
| Index Name | Market Value | 52W High | 52W Low |
|---|---|---|---|
| Nifty 50 | 24005.85 | 26373.20 | 22182.55 |
| Nifty IT | 25769.8 | 40301.40 | 25699.10 |
| Nifty Next 50 | 72100.65 | 73141.05 | 59896.10 |
| NIFTY50 USD Index | 8726.9 | 10443.40 | 8132.40 |
| Nifty Bank | 58033.05 | 61764.85 | 49954.85 |
| NIFTY Midcap 100 | 62008.8 | 62909.55 | 52032.85 |
| Nifty 500 | 23111.65 | 24144.20 | 20385.65 |
| Nifty Midcap 50 | 17716.1 | 17859.10 | 14804.55 |
| Nifty 100 | 25065.1 | 26975.15 | 22720.45 |
| Nifty FMCG | 49806.8 | 58485.05 | 45334.15 |
Latest News
OTC trade data of government securities as on July 1
NSE Corporate Bonds Trading report
Landsmill Green informs about updates
Capillary Technologies India informs about grant of stock options
Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) and the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, (‘SEBI (SBEBSE)’),as amended from time to time, Capillary Technologies India has informed that the Nomination and Remuneration Committee (NRC) of the Board of Directors of the Company granted 7,45,537 stock options of the Company of Face Value of ₹2 each, to eligible employees of the Company under the ESOP Plan 2021, vide circular resolution approved on July 01, 2026. The details pursuant to Regulation 30 of the Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30 January, 2026, as amended from time to time (‘SEBI Circulars’), with respect to the aforesaid grant of ESOPs is enclosed as an Annexure-I. The above information is also available on the Company’s website at https://www.capillarytech.com/investors/shareholder-information/corporateannouncements/.
The above information is a part of company’s filings submitted to BSE.
Dr Reddys Laboratories informs about AGM
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The previous close of DOL200 index is ₹1965.75 as of 2026-07-01.
The total volume of DOL200 index is 0.00 as of 2026-07-01.
The percentage change in value of DOL200 index is 0.17% as of 2026-07-01.
The absolute increase in DOL200 index value since the previous trading day is ₹3.4 as of 2026-07-01.
A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
